The current price movement is very very hard to understand.
.... not really in typical Mesoblast fashion all we have heard since prior to the FDA approval is how they "were ready" for sales and yet not one treatment has occurred that we are aware of almost 3 months after the FDA approval as they blame pricing, NDC, FDA etc etc for the delays ?
Add to that all the hype about how partnership discussions were ongoing for years to SI then suddenly changing that stance at the AGM with words to the effect that the "potential partners were
now waiting to see if we had what the FDA wants?" ..... almost 3 months on from the FDA approval says to me that there were no partnership MOU's signed that would be triggered upon the FDA approval for Remestemcel-L or we would have one by now (hence the need for the CR instead of a buy in or license fee to fund the coffers) so here we are .....
..... and of course the shorts warned us if you believe what has been posted on here and over yonder by multiple posters that they were going to hit Mesoblast hard and were approaching many to borrow shares but hey the
@bedger 's of the world claim the shorts aren't the problem - you can't make this stuff up ..... the below is obviously a figment of everyone's imagination as the shorts increase their position weekly when the company is supposedly now in such a great position ?
I guess we are lucky - our MSB portfolio is only down $500K from the peak today .... GG's is down circa $250 million
View attachment 6855243
(20min delay)